Celebrating 15 years
of driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

2
Oct

2. October 2023 to 4. October 2023 — Register Here

ACCESS Europe 2023 Annual Meeting & Expo

  Join leading market access, reimbursement and pricing professionals at the ACCESS Europe 2023 Annual Meeting & Expo, organized by the International Market Access Society (IMAS), as they bring together leaders and innovators from across industry, academia and agencies to share best practices and shape… read more

2
Oct

2. October 2023 to 4. October 2023 — Register Here

ACCESS 2023 Europe Annual Meeting and Expo

Join leading market access, reimbursement and pricing professionals at the ACCESS Europe 2023 Annual Meeting & Expo, organized by the International Market Access Society (IMAS), as we bring together leaders and innovators from across industry, academia and agencies to share best practices and shape the… read more

17
Oct

17. October 2023 — Register Here

EMA Clinical Trial Information System (CTIS) Information Day

The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition of their clinical trials to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and… read more

18
Oct

18. October 2023 to 19. October 2023 — Register Here

Pharmageddon: Rocket Fuel for Life Science Disruptors

Pharmageddon is a brand new event, designed to dismantle our assumptions about the status quo and recreate a better industry for patients, HCPs and ourselves. This is not a conference. Instead of testing your stamina by struggling through dozens of vendor presentations, participants will work… read more

30
Oct

30. October 2023 — Register Here

World Orphan Drug Congress 2023

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. Our credibility is shown through the prestigious advisory board that spend… read more

16
Nov

16. November 2023 — Register Here

EUCOPE’s Life Science Lectures – Episode Four

LIFE SCIENCE LECTURES – Webinar Series Episode 4  –  16 November 2023 (16:00 – 17:00 CET) Regulatory pathways: how to speed up processes for small and mid-sized companies? On the fourth episode, we will talk about regulatory pathways, and how the revised framework can improve… read more

4
Dec

4. December 2023 to 7. December 2023 — Register Here

Cell & Gene Therapy Manufacturing & Commercialization Europe

Join us in Dublin for the premier Cell & Gene Therapy Manufacturing & Commercialization Europe event on 4-7 December 2023. This groundbreaking congress is your gateway to revolutionary manufacturing, commercialization, and analytical strategies in the field! World-renowned leaders will share the latest process development, analytical… read more

14
Feb

14. February 2024 — Register Here

Europe Rare Disease Summit 2024

The European Rare Disease Summit aims to explore important developments and issues in diagnosing and treating Rare Diseases in Europe. This will be done through a series of discussions and individual talks led by experts in the field. The event will also address the obstacles… read more

12
Mar

12. March 2024 to 14. March 2024 — Register Here

DIA Europe 2024 – Collaborating for Healthcare Innovation – a focus on Sustainability!

DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration… read more

19
Mar

19. March 2024 to 20. March 2024 — Register Here

Advanced Therapies Congress 2024

The Future of Advanced Therapies 19th-20th March – ExCel, London The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators. New for 2024: Gene Editing… read more

15
May

15. May 2024 to 16. May 2024 — Registration Details

European Conference on Rare Diseases & Orphan Products (ECRD 2024)

Action Within Reach: Pioneering Solutions for Rare Diseases. The European Conference on Rare Diseases & Orphan Products (ECRD) is the largest, patient-led policy-shaping conference for rare diseases taking place in Europe. ECRD is an instrumental tool to achieve policy objectives for people living with a… read more

News & Updates

EUCOPE Member Spotlight: Q&A with SKC Consulting

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Heike Kielhorn, Managing Partner from SKC. Heike Kielhorn-Schönermark studied business administration and economics in… read more

EUCOPE Member Spotlight: Q&A with Cevidra

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Francois Lontrade, Directeur General, Laboratoire Cevidra. Before joining Cevidra, Francois Lontrade gained 18 years’… read more

EVENT RECAP – Life Science Lectures: Episode Three “‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’

On 7 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the third episode of its #LifeScienceLectures webinar series.  The focus of the webinar, titled ‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’ was to shed light on the… read more

European Parliament adopts substances of human origin (SoHO) text

On 12 September 2023, the European Parliament adopted the report on new rules governing the use of so-called substances of human origin (SoHO) intended for human application.  The Council still needs to adopt its official position, with the Spanish Presidency hoping to kick off Trilogues… read more

EUCOPE attends meeting to discuss opt-out requirements in EHDS

6 September 2023, Brussels – EUCOPE, as part of a multi-stakeholder group consisting of 32 European patient organisations, medical associations, research organisations, data collaborations and industry associations met EU officials, including MEP Tomislav Sokol, Co-Rapporteur, as well as several permanent representations that will hold upcoming… read more

Job Opening: Communications & Business Development Manager

We are looking to recruit a dynamic and experienced Communications and Business Development Manager to lead and implement our internal and external communication strategies while developing new membership and partnership opportunities for the organisation. ROLE & RESPONSIBILITIES Responsible for the overall communications activities of EUCOPE,… read more

EUCOPE Member Spotlight: Q&A with Dyne Therapeutics

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In August, we spoke with Shekhar Natarajan, Vice President – EU Regulatory Affairs, Dyne Therapeutics. Shekhar Natarajan is Vice President-… read more

🎙️Sounds of Science Podcast #17 on Real-World Evidence (RWE)

EUCOPE’s Sounds of Science Podcast – Episode 17 Real-World Evidence (RWE): The need for a multi-stakeholder approach Within the EU, the life sciences industry requires a strong innovation framework across the patient journey so that such technological advancements can be used to the benefit of… read more

EUCOPE’s first reflections on the adoption of amended report regulating substances of human origin (SoHO)

On 18 July, European lawmakers within the Health and Environment (ENVI) committee voted to adopt the amended report on Substances of Human Origin (SoHo). The report aims to improve the safety and quality standards for both donors and recipients of blood, plasma, skin, embryo, sperm,… read more

EVENT RECAP – Life Science Lectures: Episode Two “Defining (High) Unmet Medical Need (HUMN)

On 7 July, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs – hosted the second episode of its Life Science Lectures webinar series. The focus of the webinar, titled ‘’Defining (high) unmet medical need: will it steer innovation towards filling existing gaps?’’, was to dive… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership